HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Dassi, C. Articles by Brambilla, P. Search for Related Content PubMed PubMed Citation Articles by Dassi, C. Articles by Brambilla, P. Related Collections Molecular Diagnostics and Genetics

Cytochrome P450 1B1 mRNA measured in blood mononuclear cells by quantitative reverse transcription-PCR

^a Author for correspondence. Fax 39-0362383464; e-mail brambilla{at}desiolab.unimi.it.

Cytochrome P450 (CYP) 1B1 activates polycyclic aromatic hydrocarbons and aryl aromatic hydrocarbons to carcinogens. We describe a competitive reverse transcription-PCR (RT-PCR) assay for the quantification of CYP1B1 mRNA in blood mononuclear cells (BMCs) by simultaneous RT and PCR amplification of cellular RNA with decreasing amounts of an internal standard. The concentration of CYP1B1 mRNA is derived from the ratio between the intensities of the bands corresponding to the amplified products. To reduce the variability of mRNA extraction efficiency, the measured amount of CYP1B1 has been calculated in relation to the ß-actin gene products. We measured CYP1B1 expression in the BMCs of 75 human subjects; no significant differences in the CYP1B1:ß-actin ratio were detected between women (range, 0.47–4.35; median, 2.0) and men (range, 0.72–3.85; median, 2.09). The analytical imprecision (CV) of duplicates was 14% (n = 25 pairs), and the intraindividual CV for two samples, 1 month apart, was 22% (n = 20). No significant differences were detected in smokers (n = 25; range, 0.77–3.55; median, 2.14) compared with nonsmokers (n = 50; range, 0.47–4.35; median, 2.0). The method has a wide range of linearity, good sensitivity and precision, and is suitable for studies of individual susceptibility as indicated by CYP1B1 expression in BMCs.

The following articles in journals at HighWire Press have cited this article:

				G. Siest, E. Jeannesson, J.-B. Marteau, A. Samara, B. Marie, M. Pfister, and S. Visvikis-Siest Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects Drug Metab. Dispos., January 1, 2008; 36(1): 182 - 189. [Abstract] [Full Text] [PDF]

				V. Paracchini, S. Raimondi, I. T. Gram, D. Kang, N. A. Kocabas, V. N. Kristensen, D. Li, F. F. Parl, T. Rylander-Rudqvist, P. Soucek, et al. Meta- and Pooled Analyses of the Cytochrome P-450 1B1 Val432Leu Polymorphism and Breast Cancer: A HuGE-GSEC Review Am. J. Epidemiol., January 15, 2007; 165(2): 115 - 125. [Abstract] [Full Text] [PDF]

				S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237. [Abstract] [Full Text]

				J. W. Lampe, S. B. Stepaniants, M. Mao, J. P. Radich, H. Dai, P. S. Linsley, S. H. Friend, and J. D. Potter Signatures of Environmental Exposures Using Peripheral Leukocyte Gene Expression: Tobacco Smoke Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 445 - 453. [Abstract] [Full Text]

				B. Maecker, D. H. Sherr, R. H. Vonderheide, M. S. von Bergwelt-Baildon, N. Hirano, K. S. Anderson, Z. Xia, M. O. Butler, K. W. Wucherpfennig, C. O'Hara, et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells Blood, November 1, 2003; 102(9): 3287 - 3294. [Abstract] [Full Text] [PDF]

				C. Dassi, P. Brambilla, S. Signorini, P. Gerthoux, P. Molteni, R. Sala, and P. Mocarelli Quantification of Aromatic Hydrocarbon Receptor (AHR) and Related Genes by Calibrated Reverse Transcription-PCR in Blood Mononuclear Cells Clin. Chem., July 1, 2001; 47(7): 1311 - 1314. [Full Text] [PDF]

				L. T. Nguyen, M. Ramanathan, B. Weinstock-Guttman, K. Dole, C. Miller, M. Planter, K. Patrick, C. Brownscheidle, and L. D. Jacobs Detection of Cytochrome P450 and Other Drug-Metabolizing Enzyme mRNAs in Peripheral Blood Mononuclear Cells Using DNA Arrays Drug Metab. Dispos., August 1, 2000; 28(8): 987 - 993. [Abstract] [Full Text]

				B. C. Krovat, J. H. Tracy, and C. J. Omiecinski Fingerprinting of Cytochrome P450 and Microsomal Epoxide Hydrolase Gene Expression in Human Blood Cells Toxicol. Sci., June 1, 2000; 55(2): 352 - 360. [Abstract] [Full Text] [PDF]

				S. M. Heidel, K. Holston, J. T.M. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene Mol. Pharmacol., December 1, 1999; 56(6): 1317 - 1323. [Abstract] [Full Text]

				F. Fini, G. Gallinella, S. Girotti, M. Zerbini, and M. Musiani Development of a Chemiluminescence Competitive PCR for the Detection and Quantification of Parvovirus B19 DNA Using a Microplate Luminometer Clin. Chem., September 1, 1999; 45(9): 1391 - 1396. [Abstract] [Full Text] [PDF]